Skip to main content

Find Clinical Trials

Home
Conditions
Thromboembolism

Clinical trial condition

Thromboembolism

Explore clinical trials studying Thromboembolism. Study availability and eligibility vary by location and protocol.

113 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Thromboembolism trial results

Completed

Assessment of a Diagnostic Medical Device for the INR (International Normalized Ratio) Measurement

NCT02779400

Conditions: Arrhythmias, Cardiac, Cardiovascular Diseases, Embolism and Thrombosis, +8 more
Locations: Clinical research center of Grenoble university hospital Grenoble, Auvergne-Rhône-Alpes, France

View Trial Details

Completed

Apixaban Discontinuation Prior to Major Surgery

NCT02935751

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Hemorrhage, +4 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Hip Fracture Study of GSK576428 (Fondaparinux Sodium)

NCT00320424

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +1 more
Locations: GSK Investigational Site

View Trial Details

Completed

Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events

NCT02103101

Conditions: Anticoagulants, Cardiovascular Diseases, Embolism and Thrombosis, +5 more
Locations: CHU Besancon Besançon, France

View Trial Details

Completed

Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates

NCT02564718

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +1 more
Locations: Vienna, Austria

Montpellier, France

Erlangen, Germany

Ramat Gan, Israel

View Trial Details

Completed

Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas

NCT00253669

Conditions: Astrocytoma, Brain and Central Nervous System Tumors, Cardiovascular Diseases, +18 more
Locations: Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States

H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States

Winship Cancer Institute of Emory University Atlanta, Georgia, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism

NCT02864810

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +1 more
Locations: Asan Foundation Seoul, South Korea

View Trial Details

Completed

The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT

NCT02376803

Conditions: Arrhythmias, Cardiac, Atrial Fibrillation, Cardiovascular Diseases, +12 more
Locations: University of Alberta Edmonton, Alberta, Canada

Vancouver Coastal Health Research Institute Vancouver, British Columbia, Canada

View Trial Details

Completed

Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer

NCT00381888

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +39 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

Crozer-Chester Medical Center Upland, Pennsylvania, United States

View Trial Details

Completed

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

NCT02064439

Conditions: Cardiovascular Diseases, Embolism, Embolism and Thrombosis, +8 more
Locations: Beverly Hills, California, United States

La Jolla, California, United States

Ventura, California, United States

Denver, Colorado, United States

View all 266 locations

View Trial Details